Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.
Deborah SchofieldLuke RynehartRupendra N ShresthaSusan M WhiteZornitza StarkPublished in: Genetics in medicine : official journal of the American College of Medical Genetics (2019)
Use of ES in suspected monogenic disorders becomes increasingly cost-effective as the benefits of ES data reanalysis, cascade testing in first-degree relatives, and parental reproductive outcomes are incorporated into modeling.